XTL Biopharmaceuticals Ltd.
XTLB
$1.25
-$0.08-6.02%
NASDAQ
| 12/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.14M | 2.01M | 2.21M | 2.38M | 2.88M |
| Total Receivables | 99.00K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 51.00K | 29.00K | 77.00K | 118.00K | 66.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 47.00K | 11.00K | -- | -- | -- |
| Total Current Assets | 1.34M | 2.05M | 2.28M | 2.50M | 2.94M |
|
|
|||||
| Total Current Assets | 1.34M | 2.05M | 2.28M | 2.50M | 2.94M |
| Net Property, Plant & Equipment | 187.00K | -- | -- | -- | -- |
| Long-term Investments | 3.19M | -- | -- | -- | -- |
| Goodwill | 3.19M | -- | -- | -- | -- |
| Total Other Intangibles | 3.82M | 380.00K | 380.00K | 380.00K | 380.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 14.00K | -- | -- | -- | -- |
| Total Assets | 8.55M | 2.43M | 2.66M | 2.88M | 3.32M |
|
|
|||||
| Total Accounts Payable | 227.00K | 1.00K | 162.00K | 163.00K | 241.00K |
| Total Accrued Expenses | 545.00K | 205.00K | -- | -- | -- |
| Short-term Debt | 138.00K | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.30M | -- | -- | -- | -- |
| Total Other Current Liabilities | 1.30M | -- | -- | -- | -- |
| Total Current Liabilities | 2.21M | 206.00K | 162.00K | 163.00K | 241.00K |
|
|
|||||
| Total Current Liabilities | 2.21M | 206.00K | 162.00K | 163.00K | 241.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 138.00K | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 908.00K | -- | -- | -- | -- |
| Total Liabilities | 3.12M | 206.00K | 162.00K | 163.00K | 241.00K |
|
|
|||||
| Common Stock & APIC | 164.42M | 160.45M | 160.45M | 160.45M | 160.45M |
| Retained Earnings | -159.01M | -158.25M | -157.97M | -157.75M | -157.39M |
| Treasury Stock & Other | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Common Equity | 5.44M | 2.22M | 2.50M | 2.72M | 3.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.44M | 2.22M | 2.50M | 2.72M | 3.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.44M | 2.22M | 2.50M | 2.72M | 3.08M |
|
|
|||||